Insider filing · REGN
Kathryn Guarini
Director
profile →
Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · 35 filings in 24 months
ticker →
Kathryn Guarini sold $320K of Regeneron Pharmaceuticals (REGN)
Executed Aug 10, disclosed Aug 12, 2 days later.
Value, as filed
$320K
400 sh × $800.00
Executed
Aug 10
the trade date, as filed
Disclosed
Aug 12
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KGKathryn Guarini (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $360K of REGN (400 sh × $900.00, as filed), executed Oct 30.
The name
REGNHealthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kathryn Guarini in REGN
REGNSALE
Regeneron Pharmaceuticals, Inc.
$360K400 sh × $900.00
Exec Oct 30
Filed Nov 3 · 4:22 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. $340K
400 sh × $850.00
Exec Sep 2
Filed Sep 3 · 4:47 PM ET